Sex differences in the neurobiology of drug addiction

Experimental Neurology

Volumn 259, Issue , 2014, Pages 64-74

  Bobzean, Samara A M ^a   DeNobrega, Aliza K ^a   Perrotti, Linda I ^a  

^a UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

Cocaine; Conditioned place preference; Dopamine; Female; Morphine; Motivation; Negative reinforcement; Reward; Self administration; Stress

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; ESTRADIOL; ESTROGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN FOS; COCAINE; MORPHINE; SEX HORMONE;

BED NUCLEUS OF STRIA TERMINALIS; CENTRAL NUCLEUS (AMYGDALA); CORPUS STRIATUM; DISEASE COURSE; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE; ESTROGEN ACTIVITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIMBIC SYSTEM; MENTAL STRESS; MOLECULAR BIOLOGY; MOTIVATION; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVE STIMULATION; NEUROBIOLOGY; NEUROMODULATION; NEUROPHYSIOLOGY; NEUROPSYCHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REINFORCEMENT; RELAPSE; REVIEW; REWARD; SEX DIFFERENCE; STRIA TERMINALIS; VENTRAL TEGMENTUM; ADDICTION; ANIMAL; FEMALE; GENETICS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; NEGATIVE REINFORCEMENT; OVARY; PHYSIOLOGY; PLACE PREFERENCE; PSYCHOLOGICAL ASPECT; SELF-ADMINISTRATION; SEXUAL DEVELOPMENT; STRESS;

COCAINE; CONDITIONED PLACE PREFERENCE; DOPAMINE; FEMALE; MORPHINE; MOTIVATION; NEGATIVE REINFORCEMENT; REWARD; SELF-ADMINISTRATION; STRESS;

ANIMALS; DOPAMINE; FEMALE; GONADAL STEROID HORMONES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIMBIC SYSTEM; MALE; OVARY; REINFORCEMENT (PSYCHOLOGY); REWARD; SEX CHARACTERISTICS; SUBSTANCE-RELATED DISORDERS;

EID: 84907296312     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.01.022     Document Type: Review

References (226)

1. Adinoff, B., et al. Suppression of the HPA axis stress-response: implications for relapse. Alcohol. Clin. Exp. Res. 29 (2005), 1351–1355.
2. Altemus, M., et al. Reduced sensitivity to glucocorticoid feedback and reduced glucocorticoid receptor mRNA expression in the luteal phase of the menstrual cycle. Neuropsychopharmacology 17 (1997), 100–109.
3. Anderson, S.M., Pierce, R.C., Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharmacol. Ther. 106 (2005), 389–403.
4. Anker, J.J., Carroll, M.E., Sex differences in the effects of allopregnanolone on yohimbine-induced reinstatement of cocaine seeking in rats. Drug Alcohol Depend. 107 (2010), 264–267.
5. Armario, A., Gavalda, A., Marti, J., Comparison of the behavioural and endocrine response to forced swimming stress in five inbred strains of rats. Psychoneuroendocrinology 20 (1995), 879–890.
6. Aston-Jones, G., et al. The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann. N. Y. Acad. Sci. 877 (1999), 486–498.
7. Back, S.E., et al. Characteristics and correlates of men and women with prescription opioid dependence. Addict. Behav. 36 (2011), 829–834.
8. Bangasser, D.A., Valentino, R.J., Sex differences in molecular and cellular substrates of stress. Cell. Mol. Neurobiol. 32 (2012), 709–723.
9. Bardo, M.T., Bevins, R.A., Conditioned place preference: what does it add to our preclinical understanding of drug reward?. Psychopharmacology (Berl) 153 (2000), 31–43.
10. Becker, J.B., Direct effect of 17 beta-estradiol on striatum: sex differences in dopamine release. Synapse 5 (1990), 157–164.
11. Becker, J.B., Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol. Biochem. Behav. 64 (1999), 803–812.
12. Becker, J.B., Beer, M.E., The influence of estrogen on nigrostriatal dopamine activity: behavioral and neurochemical evidence for both pre- and postsynaptic components. Behav. Brain Res. 19 (1986), 27–33.
13. Becker, J.B., Hu, M., Sex differences in drug abuse. Front. Neuroendocrinol. 29 (2008), 36–47.
14. Becker, J.B., Ramirez, V.D., Sex differences in the amphetamine stimulated release of catecholamines from rat striatal tissue in vitro. Brain Res. 204 (1981), 361–372.
15. Becker, J.B., Rudick, C.N., Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: a microdialysis study. Pharmacol. Biochem. Behav. 64 (1999), 53–57.
16. Becker, J.B., Beer, M.E., Robinson, T.E., Striatal dopamine release stimulated by amphetamine or potassium: influence of ovarian hormones and the light–dark cycle. Brain Res. 311 (1984), 157–160.
17. Becker, J.B., Perry, A.N., Westenbroek, C., Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis. Biol. Sex Differ., 3, 2012, 14.
18. Bitar, M.S., et al. Modification of gonadectomy-induced increases in brain monoamine metabolism by steroid hormones in male and female rats. Psychoneuroendocrinology 16 (1991), 547–557.
19. Bobzean, S.A.M., Dennis, T.S., Addison, B.D., Perrotti, L.I., Influence of sex on reinstatement of cocaine-conditioned place preference. Brain research bulletin 83:6 (2010), 331–336, 10.1016/j.brainresbull.2010.09.003.
20. Borgkvist, A., Fisone, G., Psychoactive drugs and regulation of the cAMP/PKA/DARPP-32 cascade in striatal medium spiny neurons. Neurosci. Biobehav. Rev. 31 (2007), 79–88.
21. Brady, K.T., Randall, C.L., Gender differences in substance use disorders. Psychiatr. Clin. N. Am. 22 (1999), 241–252.
22. Brami-Cherrier, K., et al. Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation. J. Neurosci. 22 (2002), 8911–8921.
23. Brown, T.E., et al. A silent synapse-based mechanism for cocaine-induced locomotor sensitization. J. Neurosci. 31 (2011), 8163–8174.
24. Brown, Z.J., Nobrega, J.N., Erb, S., Central injections of noradrenaline induce reinstatement of cocaine seeking and increase c-fos mRNA expression in the extended amygdala. Behav. Brain Res. 217 (2011), 472–476.
25. Buffalari, D.M., et al. Corticotrophin releasing factor (CRF) induced reinstatement of cocaine seeking in male and female rats. Physiol. Behav. 105 (2012), 209–214.
26. Burgess, L.H., Handa, R.J., Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats. Endocrinology 131 (1992), 1261–1269.
27. Cameron, D.L., Williams, J.T., Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J. Neurosci. 14 (1994), 6763–6767.
28. Cami, J., et al. Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts. Br. J. Addict. 87 (1992), 1145–1151.
29. Carey, M.P., et al. The influence of ovarian steroids on hypothalamic–pituitary–adrenal regulation in the female rat. J. Endocrinol. 144 (1995), 311–321.
30. Carlezon, W.A. Jr., et al. Regulation of cocaine reward by CREB. Science 282 (1998), 2272–2275.
31. Castner, S.A., Xiao, L., Becker, J.B., Sex differences in striatal dopamine: in vivo microdialysis and behavioral studies. Brain Res. 610 (1993), 127–134.
32. Cicero, T.J., et al. Gender differences in the reinforcing properties of morphine. Pharmacol. Biochem. Behav. 65 (2000), 91–96.
33. Colby, C.R., et al. Striatal cell type-specific overexpression of DeltaFosB enhances incentive for cocaine. J. Neurosci. 23 (2003), 2488–2493.
34. Compton, W.M., Volkow, N.D., Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 83:Suppl. 1 (2006), S4–S7.
35. Cooper, O.B., Brown, T.T., Dobs, A.S., Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease. Clin. Infect. Dis. 37:Suppl. 2 (2003), S132–S136.
36. Creutz, L.M., Kritzer, M.F., Estrogen receptor-beta immunoreactivity in the midbrain of adult rats: regional, subregional, and cellular localization in the A10, A9, and A8 dopamine cell groups. J. Comp. Neurol. 446 (2002), 288–300.
37. Creutz, L.M., Kritzer, M.F., Mesostriatal and mesolimbic projections of midbrain neurons immunoreactive for estrogen receptor beta or androgen receptors in rats. J. Comp. Neurol. 476 (2004), 348–362.
38. Culm, K.E., et al. Repeated quinpirole treatment increases cAMP-dependent protein kinase activity and CREB phosphorylation in nucleus accumbens and reverses quinpirole-induced sensorimotor gating deficits in rats. Neuropsychopharmacology 29 (2004), 1823–1830.
39. Das, S., et al. NMDA and D1 receptors regulate the phosphorylation of CREB and the induction of c-fos in striatal neurons in primary culture. Synapse 25 (1997), 227–233.
40. Davis, B.A., et al. The effects of novelty-seeking phenotypes and sex differences on acquisition of cocaine self-administration in selectively bred high-responder and low-responder rats. Pharmacol. Biochem. Behav. 90 (2008), 331–338.
41. Dazzi, L., et al. Estrous cycle-dependent changes in basal and ethanol-induced activity of cortical dopaminergic neurons in the rat. Neuropsychopharmacology 32 (2007), 892–901.
42. Delfs, J.M., et al. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403 (2000), 430–434.
43. Di Chiara, G., Imperato, A., Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 85 (1988), 5274–5278.
44. Di Chiara, G., et al. Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine. Ann. N. Y. Acad. Sci. 877 (1999), 461–485.
45. Di Paolo, T., Modulation of brain dopamine transmission by sex steroids. Rev. Neurosci. 5 (1994), 27–41.
46. Di Paolo, T., Rouillard, C., Bedard, P., 17 beta-estradiol at a physiological dose acutely increases dopamine turnover in rat brain. Eur. J. Pharmacol. 117 (1985), 197–203.
47. Dietz, D.M., et al. Molecular mechanisms of psychostimulant-induced structural plasticity. Pharmacopsychiatry 42:Suppl. 1 (2009), S69–S78.
48. Dudman, J.T., et al. Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. J. Neurochem. 87 (2003), 922–934.
49. Edwards, S., Koob, G.F., Neurobiology of dysregulated motivational systems in drug addiction. Future Neurol. 5 (2010), 393–401.
50. Elman, I., Karlsgodt, K.H., Gastfriend, D.R., Gender differences in cocaine craving among non-treatment-seeking individuals with cocaine dependence. Am. J. Drug Alcohol Abuse 27 (2001), 193–202.
51. Epping-Jordan, M.P., Markou, A., Koob, G.F., The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat. Brain Res. 784 (1998), 105–115.
52. Erb, S., Stewart, J., A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J. Neurosci., 19, 1999, RC35.
53. Erb, S., et al. A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 158 (2001), 360–365.
54. Evans, S.M., The role of estradiol and progesterone in modulating the subjective effects of stimulants in humans. Exp. Clin. Psychopharmacol. 15 (2007), 418–426.
55. Evans, S.M., Foltin, R.W., Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology 31 (2006), 659–674.
56. Evans, S.M., Foltin, R.W., Pharmacokinetics of repeated doses of intravenous cocaine across the menstrual cycle in rhesus monkeys. Pharmacol. Biochem. Behav. 83 (2006), 56–66.
57. Evans, S.M., Foltin, R.W., Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates?. Horm. Behav. 58 (2010), 13–21.
58. Evans, S.M., Haney, M., Foltin, R.W., The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) 159 (2002), 397–406.
59. Everitt, B.J., Robbins, T.W., Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8 (2005), 1481–1489.
60. Everitt, B.J., Wolf, M.E., Psychomotor stimulant addiction: a neural systems perspective. J. Neurosci. 22 (2002), 3312–3320.
61. Febo, M., et al. Estrogen-dependent alterations in D2/D3-induced G protein activation in cocaine-sensitized female rats. J. Neurochem. 86 (2003), 405–412.
62. Feltenstein, M.W., Henderson, A.R., See, R.E., Enhancement of cue-induced reinstatement of cocaine-seeking in rats by yohimbine: sex differences and the role of the estrous cycle. Psychopharmacology (Berl) 216 (2011), 53–62.
63. Ferrini, M., Lima, A., De Nicola, A.F., Estradiol abolishes autologous down regulation of glucocorticoid receptors in brain. Life Sci. 57 (1995), 2403–2412.
64. Festa, E.D., Quinones-Jenab, V., Gonadal hormones provide the biological basis for sex differences in behavioral responses to cocaine. Horm. Behav. 46 (2004), 509–519.
65. Festa, E.D., et al. Sex differences in cocaine-induced behavioral responses, pharmacokinetics, and monoamine levels. Neuropharmacology 46 (2004), 672–687.
66. Forlano, P.M., Woolley, C.S., Quantitative analysis of pre- and postsynaptic sex differences in the nucleus accumbens. J. Comp. Neurol. 518 (2010), 1330–1348.
67. Francesconi, W., et al. Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalis. J. Neurosci. 29 (2009), 5389–5401.
68. Frye, C.A., Progestins influence motivation, reward, conditioning, stress, and/or response to drugs of abuse. Pharmacol. Biochem. Behav. 86 (2007), 209–219.
69. Gardner, E.L., Addiction and brain reward and antireward pathways. Adv. Psychosom. Med. 30 (2011), 22–60.
70. George, O., et al. CRF–CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 17198–17203.
71. George, O., Le Moal, M., Koob, G.F., Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems. Physiol. Behav. 106 (2012), 58–64.
72. Georges, F., Aston-Jones, G., Potent regulation of midbrain dopamine neurons by the bed nucleus of the stria terminalis. J. Neurosci., 21, 2001, RC160.
73. Gerra, G., et al. Adrenocorticotropic hormone and cortisol plasma levels directly correlate with childhood neglect and depression measures in addicted patients. Addict. Biol. 13 (2008), 95–104.
74. Gillies, G.E., McArthur, S., Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: a contribution to sex-specific neuroprotection by estrogens. Horm. Behav. 57 (2010), 23–34.
75. Graybiel, A.M., Moratalla, R., Robertson, H.A., Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. U. S. A. 87 (1990), 6912–6916.
76. Haleem, D.J., Kennett, G., Curzon, G., Adaptation of female rats to stress: shift to male pattern by inhibition of corticosterone synthesis. Brain Res. 458 (1988), 339–347.
77. Hammes, S.R., Levin, E.R., Extranuclear steroid receptors: nature and actions. Endocr. Rev. 28 (2007), 726–741.
78. Handa, R.J., et al. Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm. Behav. 28 (1994), 464–476.
79. Hedges, V.L., Staffend, N.A., Meisel, R.L., Neural mechanisms of reproduction in females as a predisposing factor for drug addiction. Front. Neuroendocrinol. 31 (2010), 217–231.
80. Heimer, L., Alheid, G.F., Piecing together the puzzle of basal forebrain anatomy. Adv. Exp. Med. Biol. 295 (1991), 1–42.
81. Heinrichs, S.C., et al. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav. Pharmacol. 6 (1995), 74–80.
82. Heinsbroek, R.P., et al. Sex- and time-dependent changes in neurochemical and hormonal variables induced by predictable and unpredictable footshock. Physiol. Behav. 49 (1991), 1251–1256.
83. Hiroi, N., et al. FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 10397–10402.
84. Holly, E.N., et al. Sex differences in behavioral and neural cross-sensitization and escalated cocaine taking as a result of episodic social defeat stress in rats. Psychopharmacology (Berl) 224 (2012), 179–188.
85. Hope, B., et al. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc. Natl. Acad. Sci. U. S. A. 89 (1992), 5764–5768.
86. Hope, B.T., et al. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13 (1994), 1235–1244.
87. Hyman, S.E., Malenka, R.C., Nestler, E.J., Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29 (2006), 565–598.
88. Ignjatova, L., Raleva, M., Gender difference in the treatment outcome of patients served in the mixed-gender program. Bratisl. Lek. Listy 110 (2009), 285–289.
89. Jackson, L.R., Robinson, T.E., Becker, J.B., Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology 31 (2006), 129–138.
90. Johnson, M.L., et al. Oestrogen receptors enhance dopamine neurone survival in rat midbrain. J. Neuroendocrinol. 22 (2010), 226–237.
91. Jones, S., Bonci, A., Synaptic plasticity and drug addiction. Curr. Opin. Pharmacol. 5 (2005), 20–25.
92. Jones, M.T., Brush, F.R., Neame, R.L., Characteristics of fast feedback control of corticotrophin release by corticosteroids. J. Endocrinol. 55 (1972), 489–497.
93. Kant, G.J., et al. Comparison of stress response in male and female rats: pituitary cyclic AMP and plasma prolactin, growth hormone and corticosterone. Psychoneuroendocrinology 8 (1983), 421–428.
94. Karami, M., Zarrindast, M.R., Morphine sex-dependently induced place conditioning in adult Wistar rats. Eur. J. Pharmacol. 582 (2008), 78–87.
95. Kelz, M.B., et al. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 401 (1999), 272–276.
96. Kitay, J.I., Sex differences in adrenal cortical secretion in the rat. Endocrinology 68 (1961), 818–824.
97. Kitay, J.I., Pituitary–adrenal function in the rat after gonadectomy and gonadal hormone replacement. Endocrinology 73 (1963), 253–260.
98. Konradi, C., et al. Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J. Neurosci. 14 (1994), 5623–5634.
99. Koob, G.F., Neural mechanisms of drug reinforcement. Ann. N. Y. Acad. Sci. 654 (1992), 171–191.
100. Koob, G.F., Neuroadaptive mechanisms of addiction: studies on the extended amygdala. Eur. Neuropsychopharmacol. 13 (2003), 442–452.
101. Koob, G.F., Alcoholism: allostasis and beyond. Alcohol. Clin. Exp. Res. 27 (2003), 232–243.
102. Koob, G.F., Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 56:Suppl. 1 (2009), 18–31.
103. Koob, G.F., The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res. 1314 (2010), 3–14.
104. Koob, G.F., Le Moal, M., Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001), 97–129.
105. Koob, G.F., Le Moal, M., Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction. Nat. Neurosci. 8 (2005), 1442–1444.
106. Koob, G.F., Le Moal, M., Addiction and the brain antireward system. Annu. Rev. Psychol. 59 (2008), 29–53.
107. Koob, G.F., Volkow, N.D., Neurocircuitry of addiction. Neuropsychopharmacology 35 (2010), 217–238.
108. Koob, G.F., Sanna, P.P., Bloom, F.E., Neuroscience of addiction. Neuron 21 (1998), 467–476.
109. Koob, G.F., Buck, C.L., Cohen, A., Edwards, S., Park, P.E., Schlosburg, J.E., George, O., et al. Addiction as a stress surfeit disorder. Neuropharmacology 76 Pt B (2014), 370–382, 10.1016/j.neuropharm.2013.05.024.
110. Kosten, T.R., Rounsaville, B.J., Kleber, H.D., Ethnic and gender differences among opiate addicts. Int. J. Addict. 20 (1985), 1143–1162.
111. Kreek, M.J., Opiate and cocaine addictions: challenge for pharmacotherapies. Pharmacol. Biochem. Behav. 57 (1997), 551–569.
112. Kritzer, M.F., Creutz, L.M., Region and sex differences in constituent dopamine neurons and immunoreactivity for intracellular estrogen and androgen receptors in mesocortical projections in rats. J. Neurosci. 28 (2008), 9525–9535.
113. Kyosseva, S.V., Mitogen-activated protein kinase signaling. Int. Rev. Neurobiol. 59 (2004), 201–220.
114. Laakso, A., Vilkman, H., Bergman, J., Haaparanta, M., Solin, O., Syvälahti, E., Hietala, J., Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects. Biological psychiatry 52:7 (2002), 759–763 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12372667.
115. Lammers, C.H., et al. Regulation of striatal dopamine receptors by estrogen. Synapse 34 (1999), 222–227.
116. Landry, M., Levesque, D., Di Paolo, T., Estrogenic properties of raloxifene, but not tamoxifen, on D2 and D3 dopamine receptors in the rat forebrain. Neuroendocrinology 76 (2002), 214–222.
117. Larson, E.B., et al. Effect of short- vs. long-term estrogen on reinstatement of cocaine-seeking behavior in female rats. Pharmacol. Biochem. Behav. 82 (2005), 98–108.
118. Le Mevel, J.C., et al. Temporal changes in plasma adrenocorticotropin concentration after repeated neurotropic stress in male and female rats. Endocrinology 105 (1979), 812–817.
119. Le Saux, M., Morissette, M., Di Paolo, T., ERbeta mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens. Neuropharmacology 50 (2006), 451–457.
120. Leri, F., et al. Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J. Neurosci. 22 (2002), 5713–5718.
121. Levesque, D., Di Paolo, T., Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17 beta-estradiol. Neurosci. Lett. 88 (1988), 113–118.
122. Levesque, D., Di Paolo, T., Chronic estradiol treatment increases ovariectomized rat striatal D-1 dopamine receptors. Life Sci. 45 (1989), 1813–1820.
123. Lu, L., et al. Role of ERK in cocaine addiction. Trends Neurosci. 29 (2006), 695–703.
124. Lukas, S.E., et al. Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology (Berl) 125 (1996), 346–354.
125. Lynch, W.J., Carroll, M.E., Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats. Psychopharmacology (Berl) 144 (1999), 77–82.
126. Lynch, W.J., Arizzi, M.N., Carroll, M.E., Effects of sex and the estrous cycle on regulation of intravenously self-administered cocaine in rats. Psychopharmacology (Berl) 152 (2000), 132–139.
127. Lynch, W.J., et al. Role of estrogen in the acquisition of intravenously self-administered cocaine in female rats. Pharmacol. Biochem. Behav. 68 (2001), 641–646.
128. Lynch, W.J., et al. Effect of cocaine self-administration on striatal PKA-regulated signaling in male and female rats. Psychopharmacology (Berl) 191 (2007), 263–271.
129. Maj, M., et al. Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala. Neuropeptides 37 (2003), 105–110.
130. McClung, C.A., Nestler, E.J., Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat. Neurosci. 6 (2003), 1208–1215.
131. McEwen, B.S., Alves, S.E., Estrogen actions in the central nervous system. Endocr. Rev. 20 (1999), 279–307.
132. Merlo Pich, E., et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15 (1995), 5439–5447.
133. Miller, C.A., Marshall, J.F., Molecular substrates for retrieval and reconsolidation of cocaine-associated contextual memory. Neuron 47 (2005), 873–884.
134. Mirbaha, H., et al. Estrogen pretreatment modulates morphine-induced conditioned place preference in ovariectomized mice. Pharmacol. Biochem. Behav. 92 (2009), 399–403.
135. Moratalla, R., et al. Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17 (1996), 147–156.
136. Morissette, M., Biron, D., Di Paolo, T., Effect of estradiol and progesterone on rat striatal dopamine uptake sites. Brain Res. Bull. 25 (1990), 419–422.
137. Morissette, M., et al. Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain. J. Steroid Biochem. Mol. Biol. 108 (2008), 327–338.
138. Munro, C.A., McCaul, M.E., Wong, D.F., Oswald, L.M., Zhou, Y., Brasic, J., Wand, G.S., Sex differences in striatal dopamine release in healthy adults. Biological psychiatry 59:10 (2006), 966–974, 10.1016/j.biopsych.2006.01.008.
139. Nazarian, A., et al. Sex differences in basal and cocaine-induced alterations in PKA and CREB proteins in the nucleus accumbens. Psychopharmacology (Berl) 203 (2009), 641–650.
140. Nestler, E.J., Molecular neurobiology of addiction. Am. J. Addict. 10 (2001), 201–217.
141. Nestler, E.J., Common molecular and cellular substrates of addiction and memory. Neurobiol. Learn. Mem. 78 (2002), 637–647.
142. Nestler, E.J., From neurobiology to treatment: progress against addiction. Nat. Neurosci.(5 Suppl.), 2002, 1076–1079.
143. Nestler, E.J., Barrot, M., Self, D.W., DeltaFosB: a sustained molecular switch for addiction. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 11042–11046.
144. Niyomchai, T., et al. Progesterone inhibits behavioral responses and estrogen increases corticosterone levels after acute cocaine administration. Pharmacol. Biochem. Behav. 80 (2005), 603–610.
145. Nye, H.E., et al. Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J. Pharmacol. Exp. Ther. 275 (1995), 1671–1680.
146. Nygard, S.K., et al. Sexually dimorphic intracellular responses after cocaine-induced conditioned place preference expression. Brain Res. 1520 (2013), 121–133.
147. O'Dell, L.E., Torres, O.V., A mechanistic hypothesis of the factors that enhance vulnerability to nicotine use in females. Neuropharmacology 76 Pt B (2014), 566–580, 10.1016/j.neuropharm.2013.04.055.
148. Olds, D., An objective consideration of dairy herd fertility. J. Am. Vet. Med. Assoc. 154 (1969), 253–260.
149. Olds, J., Milner, P., Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J. Comp. Physiol. Psychol. 47 (1954), 419–427.
150. Olive, M.F., et al. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol. Biochem. Behav. 72 (2002), 213–220.
151. Olson, V.G., et al. Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area. J. Neurosci. 25 (2005), 5553–5562.
152. Owesson-White, C.A., et al. Neural encoding of cocaine-seeking behavior is coincident with phasic dopamine release in the accumbens core and shell. Eur. J. Neurosci. 30 (2009), 1117–1127.
153. Pacak, K., et al. Effects of immobilization on in vivo release of norepinephrine in the bed nucleus of the stria terminalis in conscious rats. Brain Res. 688 (1995), 242–246.
154. Patchev, V.K., et al. Implications of estrogen-dependent brain organization for gender differences in hypothalamo-pituitary-adrenal regulation. FASEB J. 9 (1995), 419–423.
155. Peris, J., et al. Estradiol enhances behavioral sensitization to cocaine and amphetamine-stimulated striatal [3H]dopamine release. Brain Res. 566 (1991), 255–264.
156. Perrotti, L.I., et al. DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment. Eur. J. Neurosci. 21 (2005), 2817–2824.
157. Perrotti, L.I., et al. Distinct patterns of DeltaFosB induction in brain by drugs of abuse. Synapse 62 (2008), 358–369.
158. Phillips, G.D., et al. Immunohistochemical assessment of mesotelencephalic dopamine activity during the acquisition and expression of Pavlovian versus instrumental behaviours. Neuroscience 117 (2003), 755–767.
159. Piazza, P.V., Deroche-Gamonet, V., A multistep general theory of transition to addiction. Psychopharmacology (Berl) 229 (2013), 387–413.
160. Pich, E.M., et al. Common neural substrates for the addictive properties of nicotine and cocaine. Science 275 (1997), 83–86.
161. Pierce, R.C., Kalivas, P.W., Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J. Neurosci. 17 (1997), 3254–3261.
162. Pierce, R.C., Kumaresan, V., The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?. Neurosci. Biobehav. Rev. 30 (2006), 215–238.
163. Pohjalainen, T., Rinne, J.O., Någren, K., Syvälahti, E., Hietala, J., Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. The American journal of psychiatry 155:6 (1998), 768–773 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9619148.
164. Quinones-Jenab, V., et al. Estrous cycle differences in cocaine-induced stereotypic and locomotor behaviors in Fischer rats. Behav. Brain Res. 101 (1999), 15–20.
165. Richter, R.M., Weiss, F., In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 32 (1999), 254–261.
166. Rivier, C., Gender, sex steroids, corticotropin-releasing factor, nitric oxide, and the HPA response to stress. Pharmacol. Biochem. Behav. 64 (1999), 739–751.
167. Robbins, S.J., et al. Comparing levels of cocaine cue reactivity in male and female outpatients. Drug Alcohol Depend. 53 (1999), 223–230.
168. Roberts, D.C., Breaking points on a progressive ratio schedule reinforced by intravenous apomorphine increase daily following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 32 (1989), 43–47.
169. Roberts, D.C., Bennett, S.A., Vickers, G.J., The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology (Berl) 98 (1989), 408–411.
170. Robinson, T.E., Kolb, B., Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J. Neurosci. 17 (1997), 8491–8497.
171. Robinson, T.E., Kolb, B., Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11 (1999), 1598–1604.
172. Robinson, T.E., Kolb, B., Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse 33 (1999), 160–162.
173. Rodriguez de Fonseca, F., et al. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276 (1997), 2050–2054.
174. Roth, M.E., Carroll, M.E., Sex differences in the escalation of intravenous cocaine intake following long- or short-access to cocaine self-administration. Pharmacol. Biochem. Behav. 78 (2004), 199–207.
175. Roth, M.E., Casimir, A.G., Carroll, M.E., Influence of estrogen in the acquisition of intravenously self-administered heroin in female rats. Pharmacol. Biochem. Behav. 72 (2002), 313–318.
176. Rousseau, G.G., Baxter, J.D., Tomkins, G.M., Glucocorticoid receptors: relations between steroid binding and biological effects. J. Mol. Biol. 67 (1972), 99–115.
177. Russell, S.E., Rachlin, A.B., Smith, K.L., Muschamp, J., Berry, L., Zhao, Z., Chartoff, E.H., Sex Differences in Sensitivity to the Depressive-like Effects of the Kappa Opioid Receptor Agonist U-50488 in Rats. Biological psychiatry, 1–10, 2013, 10.1016/j.biopsych.2013.07.042.
178. Russo, S.J., et al. Gonadal hormones differentially modulate cocaine-induced conditioned place preference in male and female rats. Neuroscience 120 (2003), 523–533.
179. Russo, S.J., et al. Sex differences in the conditioned rewarding effects of cocaine. Brain Res. 970 (2003), 214–220.
180. Substance Abuse and Mental Health Services Administration (SAMHSA), Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-44 (HHS Publication No. (SMA) 12–4713), 2012, MD: Author, Rockville.
181. Schulteis, G., et al. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose–response analysis. J. Pharmacol. Exp. Ther. 271 (1994), 1391–1398.
182. Shaham, Y., Erb, S., Stewart, J., Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res. Brain Res. Rev. 33 (2000), 13–33.
183. Shieh, K.R., Yang, S.C., Effects of estradiol on the stimulation of dopamine turnover in mesolimbic and nigrostriatal systems by cocaine- and amphetamine-regulated transcript peptide in female rats. Neuroscience 154 (2008), 1589–1597.
184. Shimizu, H., Bray, G.A., Effects of castration, estrogen replacement and estrus cycle on monoamine metabolism in the nucleus accumbens, measured by microdialysis. Brain Res. 621 (1993), 200–206.
185. Sinha, R., How does stress increase risk of drug abuse and relapse?. Psychopharmacology (Berl) 158 (2001), 343–359.
186. Sinha, R., Chronic stress, drug use, and vulnerability to addiction. Ann. N. Y. Acad. Sci. 1141 (2008), 105–130.
187. Sircar, R., Kim, D., Female gonadal hormones differentially modulate cocaine-induced behavioral sensitization in Fischer, Lewis, and Sprague–Dawley rats. J. Pharmacol. Exp. Ther. 289 (1999), 54–65.
188. Sofuoglu, M., et al. Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp. Clin. Psychopharmacol. 7 (1999), 274–283.
189. Sofuoglu, M., Mitchell, E., Kosten, T.R., Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacol. Biochem. Behav. 78 (2004), 699–705.
190. Sterling, R.C., et al. Gender differences in cue exposure reactivity and 9-month outcome. J. Subst. Abus. Treat. 27 (2004), 39–44.
191. Tennant, F., et al. Abnormal adrenal gland metabolism in opioid addicts: implications for clinical treatment. J. Psychoactive Drugs 23 (1991), 135–149.
192. Terner, J.M., de Wit, H., Menstrual cycle phase and responses to drugs of abuse in humans. Drug Alcohol Depend. 84 (2006), 1–13.
193. Thompson, T.L., Moss, R.L., Estrogen regulation of dopamine release in the nucleus accumbens: genomic- and nongenomic-mediated effects. J. Neurochem. 62 (1994), 1750–1756.
194. Ungerstedt, U., Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. Suppl. 367 (1971), 69–93.
195. Ungerstedt, U., Ljungberg, T., Steg, G., Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons. Adv. Neurol. 5 (1974), 421–426.
196. Valjent, E., et al. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 491–496.
197. Van Hartesveldt, C., Joyce, J.N., Effects of estrogen on the basal ganglia. Neurosci. Biobehav. Rev. 10 (1986), 1–14.
198. Viau, V., Meaney, M.J., Variations in the hypothalamic–pituitary–adrenal response to stress during the estrous cycle in the rat. Endocrinology 129 (1991), 2503–2511.
199. Volkow, N.D., Fowler, J.S., Wang, G.-J., Swanson, J.M., Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Molecular psychiatry 9:6 (2004), 557–569, 10.1038/sj.mp.4001507.
200. Walker, Q.D., et al. Sex differences in cocaine-stimulated motor behavior: disparate effects of gonadectomy. Neuropsychopharmacology 25 (2001), 118–130.
201. Walker, Q.D., Ray, R., Kuhn, C.M., Sex differences in neurochemical effects of dopaminergic drugs in rat striatum. Neuropsychopharmacology 31 (2006), 1193–1202.
202. Walter, M., et al. Cortisol concentrations, stress-coping styles after withdrawal and long-term abstinence in alcohol dependence. Addict. Biol. 11 (2006), 157–162.
203. Walters, C.L., Blendy, J.A., Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse. J. Neurosci. 21 (2001), 9438–9444.
204. Walters, C.L., Kuo, Y.C., Blendy, J.A., Differential distribution of CREB in the mesolimbic dopamine reward pathway. J. Neurochem. 87 (2003), 1237–1244.
205. Wang, J., et al. Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Psychopharmacology (Berl) 185 (2006), 19–28.
206. Weiner, J., et al. PKA-mediated responses in females' estrous cycle affect cocaine-induced responses in dopamine-mediated intracellular cascades. Neuroscience 161 (2009), 865–876.
207. Wise, R.A., Dopamine, learning and motivation. Nature reviews. Neuroscience 5:6 (2004), 483–494, 10.1038/nrn1406.
208. Wissman, A.M., et al. Sex differences and effects of cocaine on excitatory synapses in the nucleus accumbens. Neuropharmacology 61 (2011), 217–227.
209. Wissman, A.M., May, R.M., Woolley, C.S., Ultrastructural analysis of sex differences in nucleus accumbens synaptic connectivity. Brain Struct. Funct. 217 (2012), 181–190.
210. Wolf, M.E., Mangiavacchi, S., Sun, X., Mechanisms by which dopamine receptors may influence synaptic plasticity. Ann. N. Y. Acad. Sci. 1003 (2003), 241–249.
211. Xiao, L., Becker, J.B., Quantitative microdialysis determination of extracellular striatal dopamine concentration in male and female rats: effects of estrous cycle and gonadectomy. Neurosci. Lett. 180 (1994), 155–158.
212. Yan, Z., et al. D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 11607–11612.
213. Yates, W.R., et al. Descriptive and predictive validity of a high-risk alcoholism relapse model. J. Stud. Alcohol 54 (1993), 645–651.
214. Yoshimura, S., et al. Sex-differences in adrenocortical responsiveness during development in rats. Steroids 68 (2003), 439–445.
215. Young, E.A., The role of gonadal steroids in hypothalamic–pituitary–adrenal axis regulation. Crit. Rev. Neurobiol. 9 (1995), 371–381.
216. Young, E.A., Sex differences in response to exogenous corticosterone: a rat model of hypercortisolemia. Mol. Psychiatry 1 (1996), 313–319.
217. Young, S.T., Porrino, L.J., Iadarola, M.J., Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. U. S. A. 88 (1991), 1291–1295.
218. Young, E.A., et al. Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats. Neuropsychopharmacology 25 (2001), 881–891.
219. Zakharova, E., Wade, D., Izenwasser, S., Sensitivity to cocaine conditioned reward depends on sex and age. Pharmacol. Biochem. Behav. 92 (2009), 131–134.
220. Zhang, L., et al. Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J. Neurosci. 24 (2004), 3344–3354.
221. Zhang, D., et al. Estrogen regulates responses of dopamine neurons in the ventral tegmental area to cocaine. Psychopharmacology (Berl) 199 (2008), 625–635.
222. Zhang, L., et al. Signaling via dopamine D1 and D3 receptors oppositely regulates cocaine-induced structural remodeling of dendrites and spines. Neurosignals 20 (2012), 15–34.
223. Zhou, W., Cunningham, K.A., Thomas, M.L., Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats. Brain Res. Mol. Brain Res. 100 (2002), 75–83.
224. Zilberman, M., Tavares, H., el-Guebaly, N., Gender similarities and differences: the prevalence and course of alcohol- and other substance-related disorders. J. Addict. Dis. 22 (2003), 61–74.
225. Zilberman, M.L., et al. Substance use disorders: sex differences and psychiatric comorbidities. Can. J. Psychiatry 48 (2003), 5–13.
226. Zorrilla, E.P., et al. Extended access cocaine self-administration differentially activates dorsal raphe and amygdala corticotropin-releasing factor systems in rats. Addict. Biol. 17 (2012), 300–308.